— · biotechnology · rna · therapeutics
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series A · May 2026 · $54M
Qiming Venture Partners lead, Highlight Capital, Apricot Capital, TF Capital
Reported by Ventureburn
Missing a round, or an investor who was in one? Tell us.